Legal Representation
Attorney
Alexander Ruzzier
USPTO Deadlines
Next Deadline
1685 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240813)
Due Date
August 13, 2030
Grace Period Ends
February 13, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 13, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 13, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 28, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 28, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 8, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 22, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 9, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 12, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 10, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 12, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development services performed for others in the fields of drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, and biological products; Laboratory research and development services relating to the production of antibodies; Research and development services in the field of antibodies; Medical and Scientific research and development in the fields of cancer, immunological-inflammatory chronic conditions, tissue repair, biology, laboratory testing, biotechnology, biochemistry, and medicine; Research and product development services for others in the fields of cancer, immunological-inflammatory chronic conditions, tissue repair, biology, laboratory testing, biotechnology, biochemistry, and medicine; Providing information on the subject of scientific research in the fields of cancer, immunological-inflammatory chronic conditions, tissue repair, biology, laboratory testing, biotechnology, biochemistry, and medicine; Biotechnology research; Pharmaceutical research and development; Pharmaceutical research services; Scientific and technological services, namely, research and development in the field of discovery, design, and development of antigen-binding molecules, using artificial intelligence and other computer-aided computational techniques, and laboratory services relating to the aforesaid molecular discovery, design, and development
First Use Anywhere:
Nov 5, 2022
First Use in Commerce:
Nov 5, 2022
Additional Information
Design Mark
The mark consists of the literal element "CHANTIBODY" in stylized font along with a radial three-loop design element in the upper right corner.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording "CHANTIBODY" has no meaning in a foreign language.
Classification
International Classes
042